The mythical Fountain of Youth may be an actual component of our physiology. Aging is not simply the body breaking down against the calendar, it is a coordinated series of molecular/biochemical changes that occur with time. There is an active hypothesis that later-life medical issues are not just happening as we age, but are actually caused by aging, meaning there are potential drug targets that may slow the process. BioAge performed -omics level analysis on populations of aging individuals, revealing patterns of proteins and metabolites that may be causal components of the aging process. New therapeutics seek to target aspects of human senescence, potentially delaying the onset of late-life disease. Dr. Eric Morgen of BioAge describes how his company has used a novel approach to identify new compounds that may play eventual roles in slowing the aging process.
Get your whole lab on the same page today.Learn more